Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study

We examined whether rurality, social inequity, and racialized segregation across communities from four states in the HEALing Communities Study (HCS) were associated with 1) greater perceived community stigma toward people treated for opioid use disorder (OUD), 2) greater perceived intervention stigma toward medications for opioid use disorder (MOUD), and 3) greater perceived intervention stigma toward naloxone by community stakeholders in the HEALing Communities Study (HCS).